Central choline suppresses plasma renin response to graded haemorrhage in rats

Naciye Isbil-Buyukcoskun1, Yesim O Ilcol, Mehmet Cansev

  • 1Department of Physiology, Uludag University Medical School, Bursa, Turkey.

Insights

Central choline administration inhibits the renin-angiotensin system during hemorrhage, mediated by nicotinic receptors and vasopressin. This suggests a novel mechanism for blood pressure regulation involving choline.

Area of Science:

  • Neuroscience
  • Cardiovascular Physiology
  • Pharmacology

Background:

  • Central choline administration elevates blood pressure via vasopressin and catecholamines.
  • The renin-angiotensin system is a key pressor system.
  • The effect of choline on the renin-angiotensin pathway is unknown.

Purpose of the Study:

  • To investigate the effect of central choline administration on the renin-angiotensin pathway during hemorrhage.
  • To explore the involvement of nicotinic and muscarinic receptors, vasopressin, and catecholamines.

Main Methods:

  • Rats received intracerebroventricular (i.c.v.) choline and were subjected to graded hemorrhage.
  • Plasma renin activity (PRA), blood pressure, vasopressin, and catecholamines were measured.
  • Receptor antagonists (mecamylamine, atropine) and a vasopressin antagonist were used.

Main Results:

  • Central choline (i.c.v.) inhibited the increase in PRA during hemorrhage.
  • Central choline increased blood pressure and enhanced vasopressin and catecholamine levels.
  • The PRA inhibition was blocked by mecamylamine (nicotinic antagonist) but not atropine (muscarinic antagonist).
  • A vasopressin antagonist reversed the PRA inhibition but not the blood pressure increase.

Conclusions:

  • Central choline administration inhibits the plasma renin response to hemorrhage.
  • This effect involves activation of nicotinic receptors and increased plasma vasopressin.
  • Choline modulates cardiovascular regulation through multiple pressor systems.

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...